Published Date: 31-May-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Anastomosis Devices Market size is expected to reach $4.8 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period.
The Reusable segment is showcasing a CAGR of 10.3% during (2022 - 2028). The reusable anastomotic device is a new segment of the anastomosis device market. Some of the key drivers expected to boost the segment's growth in the coming years include the emergence of technologically improved items and the growing desire to eliminate biomedical waste. Moreover, the rapidly increasing concerns about environmental conservation are one of the major reasons that is accelerating the utilization of reusable products. This factor is significantly expediting the growth of this segment of the anastomosis device market.
The Cardiovascular Surgery segment acquired maximum revenue share in the Global Anastomosis Devices Market by Application 2021, thereby, achieving a market value of $2.5 billion by 2028. The increasing number of cardiovascular surgeries is owing to the rising geriatric population all over the world. In addition, the high prevalence of cardiovascular disease (CVD) is contributing to a rise in the frequency of heart procedures like CABG. Therefore, the growth of this segment is being propelled due to this factor.
The Ambulatory Care Centers & Clinics segment has shown growth rate of 6.1% during (2022 - 2028). The rising demand for outpatient care, which is both cost-effective and eliminates the requirement for a hospital stay, is anticipated to be the primary driver adoption of ambulatory care centers and clinics. In addition, government initiatives along with the availability of investments for ambulatory healthcare facilities are encouraging people to shift to these services. Hence, this factor is propelling the growth of this segment of the market.
The North America is the fastest growing region in the dominated the Global Anastomosis Devices Market by Region 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.7 billion by 2028. The Asia Pacific market is estimated to witness a CAGR of 7.2% during (2022 - 2028). Additionally, The Europe market would exhibit a CAGR of 4.7% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By End User
Unique Offerings from KBV Research